Related Experiment Video

Updated: Oct 11, 2025

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

10.8K

Triple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes. Reply

Peter J Barry1, Marcus A Mall2, Deepika Polineni3

  • 1Manchester University NHS Foundation Trust, Manchester, United Kingdom.

The New England Journal of Medicine
|December 7, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

19.5K
Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice
08:55

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

7.9K

Related Experiment Videos

Last Updated: Oct 11, 2025

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

10.8K
Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

19.5K
Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice
08:55

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

7.9K

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

238
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
238
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

394
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
394

Articles linked to this work by shared authors, journal, and citation graph.

Carbocisteine Reduces Airway Mucus Obstruction and Alters Inflammatory Cell Populations in a Model of Muco-Obstructive Lung Disease.

Immunology and cell biology·2026

Preventive intrapulmonary treatment with Ligilactobacillus murinus reduces airway inflammation and mucus plugging in mice with cystic fibrosis-like lung disease.

ERJ open research·2026

Efficient AI-supported quantification of network structures in SEM imaged human mucus: A detailed protocol.

American journal of physiology. Lung cellular and molecular physiology·2026

The role of sweat chloride in determining CFTR protein restoration in people with cystic fibrosis.

The Lancet. Respiratory medicine·2026

Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research.

American journal of respiratory and critical care medicine·2026

Pulmonary exacerbations in patients with genetically confirmed PCD: a prospective observational multicentre study.

Frontiers in molecular biosciences·2026

Evidence-Based Tobacco-Cessation Strategies for Low- and Middle-Income Countries.

The New England journal of medicine·2026

Multiagent Large Language Model Framework for Psychotherapy Fidelity Assessment in Motivational Interviewing and Cognitive Behavioral Therapy Training: Cross-Sectional, Simulation-Based Evaluation Study.

JMIR medical education·2026

Beyond diagnosis in general practice: Predictive processing, a novel framework for persistent physical symptoms.

The European journal of general practice·2026

Cognitive Vulnerability and Multimodal Communicative-Pragmatic Difficulty in Subclinical Aging: A MoCA-Guided Exploration.

Experimental aging research·2026

ISIT-GEN: An in silico imaging trial to assess the inter-scanner generalizability of CTLESS for myocardial perfusion SPECT on defect-detection task.

Proceedings of SPIE--the International Society for Optical Engineering·2026

Phenotyping of chronic lung allograft dysfunction in the ScanCLAD study: a research letter.

ERJ open research·2026

The Development of Cyberchondria Amid the Pandemic: An Autoregressive Cross-Lagged Model.

Health communication·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us